Form 8-K - Current report:
SEC Accession No. 0001193805-21-001224
Filing Date
2021-08-26
Accepted
2021-08-26 16:15:33
Documents
12
Period of Report
2021-08-20
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 e620900_8k-arct.htm   iXBRL 8-K 22919
  Complete submission text file 0001193805-21-001224.txt   195162

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20210820.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210820_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210820_pre.xml EX-101.PRE 22362
5 EXTRACTED XBRL INSTANCE DOCUMENT e620900_8k-arct_htm.xml XML 3626
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 211212528
SIC: 2834 Pharmaceutical Preparations